Atossa Therapeutics Inc (ATOS)
1.52
+0.02
(+1.33%)
USD |
NASDAQ |
Apr 25, 16:00
1.525
0.00 (0.00%)
Pre-Market: 20:00
Atossa Therapeutics Enterprise Value: 102.00M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 102.00M |
| April 24, 2024 | 99.50M |
| April 23, 2024 | 98.24M |
| April 22, 2024 | 89.47M |
| April 19, 2024 | 83.21M |
| April 18, 2024 | 89.47M |
| April 17, 2024 | 80.70M |
| April 16, 2024 | 104.51M |
| April 15, 2024 | 125.81M |
| April 12, 2024 | 119.54M |
| April 11, 2024 | 133.33M |
| April 10, 2024 | 130.82M |
| April 09, 2024 | 142.10M |
| April 08, 2024 | 130.82M |
| April 05, 2024 | 145.86M |
| April 04, 2024 | 174.68M |
| April 03, 2024 | 165.28M |
| April 02, 2024 | 142.10M |
| April 01, 2024 | 162.15M |
| March 28, 2024 | 137.09M |
| March 27, 2024 | 140.85M |
| March 26, 2024 | 137.09M |
| March 25, 2024 | 148.36M |
| March 22, 2024 | 120.80M |
| March 21, 2024 | 122.05M |
| Date | Value |
|---|---|
| March 20, 2024 | 115.79M |
| March 19, 2024 | 105.76M |
| March 18, 2024 | 73.18M |
| March 15, 2024 | 73.18M |
| March 14, 2024 | 60.32M |
| March 13, 2024 | 67.76M |
| March 12, 2024 | 73.96M |
| March 11, 2024 | 60.32M |
| March 08, 2024 | 46.68M |
| March 07, 2024 | 47.92M |
| March 06, 2024 | 54.12M |
| March 05, 2024 | 38.00M |
| March 04, 2024 | 38.00M |
| March 01, 2024 | 35.52M |
| February 29, 2024 | 32.67M |
| February 28, 2024 | 35.52M |
| February 27, 2024 | 39.24M |
| February 26, 2024 | 33.06M |
| February 23, 2024 | 33.04M |
| February 22, 2024 | 38.00M |
| February 21, 2024 | 36.76M |
| February 20, 2024 | 38.00M |
| February 16, 2024 | 36.76M |
| February 15, 2024 | 36.76M |
| February 14, 2024 | 39.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-53.80M
Minimum
Dec 28 2022
903.93M
Maximum
Jun 25 2021
55.19M
Average
7.800M
Median
Jun 07 2022
Enterprise Value Benchmarks
| AngioDynamics Inc | 153.06M |
| Biolase Inc | 14.50M |
| Outset Medical Inc | 46.99M |
| Perspective Therapeutics Inc | 931.55M |
| Electromed Inc | 128.80M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.754M |
| Total Expenses (Quarterly) | 9.019M |
| EPS Diluted (Quarterly) | -0.06 |
| Earnings Yield | -15.79% |
| Normalized Earnings Yield | -5132.69 |